GU Cancers 2019 | QoL in bladder cancer
Health-related quality of life (QoL) assessments are important in evaluating the care of cancer patients. Srikala Sridhar, MD, FRCPC, of the Princess Margaret Cancer Centre, Toronto, ON, reports that QoL remains poorly standardized in bladder cancer, and stresses the need for a better way to assess QoL in order to compare the potentiality of bladder cancer drugs in clinical trials. This video was taken at the 2019 Genitourinary Cancers Symposium, held in San Francisco, CA.
Get great new content delivered to your inboxSign up